drugset
drugset / Trial / NCT03632668

Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072

NCT03632668 ↗

Phase 1 Completed 38 enrolled Addpharma Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the Pharmacokinetic Interaction Between AD-2071 and AD-2072 in healthy male volunteers.

Timeline

Start
2018-09-28
Primary completion
2019-01-24
Completion
2019-01-24

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-2071 Unknown — —
Subject AD-2072 Unknown — —

Indications

hyperlipidemia hypertensive disorder